Lite Strategy Inc (LITS) Stock Price, Quote & News

Company Profile

Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.

Industry: Biotechnology

Sector: Healthcare

Phone: 858 369 7100

Website: www.litestrategy.com

Address:

9920 Pacific Heights Blvd., Suite 150, San Diego, United States

kpfwutShr43 Nov. 15 at 1:26 PM

$LITS fasten your seatbelts for several 100% incoming. Buyback, ETF around corner. $LTC.X Litecoin altcoin season starting, don't care for $BTC.X anymore. Oldest and most undervalued coin. Let's go 🚀🚀🚀

1 · Reply

TheBullishStockTrader Nov. 15 at 12:53 PM

$CYPH $ZEC.X $LTC.X $LITS 4 plays that about to make moves

0 · Reply

TheBullishStockTrader Nov. 15 at 3:00 AM

$LTC.X ohhhh yeaaaaa $LITS

0 · Reply

TheBullishStockTrader Nov. 14 at 7:53 PM

$LITS It's so quiet in here before it gets crazy...........

0 · Reply

TheBullishStockTrader Nov. 14 at 6:14 PM

$LITS Coin*

0 · Reply

TheBullishStockTrader Nov. 14 at 4:48 PM

$LITS i am the only LiTS guy around it seems I will be rich myself 😂

1 · Reply

TheBullishStockTrader Nov. 14 at 3:43 PM

$LITS LiTS looking like it could gap up here watching litecoin closely

0 · Reply

TheBullishStockTrader Nov. 14 at 3:30 PM

$CYPH Also it some $LITS the goal in trading is to be there before the pump thank me later 💪

0 · Reply

TheBullishStockTrader Nov. 14 at 3:17 PM

$CYPH also Front load $LITS guys bith of these are treasuries ones ZeC one LTC and both coins will be massively adopted soon

0 · Reply

soccerplayer06 Nov. 14 at 3:01 PM

$LITS curious when they will make any more moves on progressing Litecoin and its adoption. $LTC.X

0 · Reply

MEI Pharma, Inc. Rebrands as Lite Strategy, Inc., Adopts New NASDAQ Ticker ‘LITS'

Aug 5, 2025, 8:00 AM EDT - 3 months ago

MEI Pharma Acquires Litecoin, Launches $100M Institutional Treasury Strategy with Charlie Lee and GSR Advising

Jul 24, 2025, 8:00 PM EDT - 4 months ago

BTC digital asset field continues to exert its strength, HASHJ launches Bitcoin cloud mining platform with "capital + technology" dual-driven mode

Jul 22, 2025, 4:35 PM EDT - 4 months ago

MEI Pharma Announces Closing of $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange

Jul 18, 2025, 1:22 PM EDT - 4 months ago

Why Is MEI Pharma Stock Soaring On Friday?

Jul 18, 2025, 8:30 AM EDT - 4 months ago

MEI Pharma Announces $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange

May 13, 2025, 4:05 PM EDT - 6 months ago

MEI Pharma Reports Third Quarter Fiscal Year 2025 Cash Position

Feb 12, 2025, 4:12 PM EST - 9 months ago

MEI Pharma Reports Second Quarter Fiscal Year 2025 Cash Position

Nov 12, 2024, 4:05 PM EST - 1 year ago

MEI Pharma Reports First Quarter Fiscal Year 2025 Cash Position

Sep 19, 2024, 4:01 PM EDT - 1 year ago

MEI Pharma Reports Fiscal Year End 2024 Cash Position

Aug 12, 2024, 8:30 AM EDT - 1 year ago

MEI Pharma Engages Oppenheimer & Co. Inc. to Assist in Evaluating Strategic Alternatives

Jul 22, 2024, 8:30 AM EDT - 1 year ago

MEI Pharma to Consider Strategic Alternatives

May 14, 2024, 10:38 AM EDT - 1 year ago

Glancy Prongay & Murray LLP Announces Investigation of MEI Pharma, Inc. (MEIP)

May 9, 2024, 4:02 PM EDT - 1 year ago

MEI Pharma Reports Third Quarter Fiscal Year 2024 Results and Operational Highlights

Apr 11, 2024, 8:02 AM EDT - 1 year ago

MEI Pharma Board of Directors Aligns on Strategy to Advance Voruciclib and ME-344

Apr 11, 2024, 8:00 AM EDT - 1 year ago

MEI Pharma Reports Initial Data from Clinical Study Evaluating ME-344 in Combination with Bevacizumab (Avastin®) in Relapsed Metastatic Colorectal Cancer Patients

Apr 10, 2024, 8:00 AM EDT - 1 year ago

MEI Pharma to Present at the Stifel 2024 Virtual Targeted Oncology Forum

$MEI Pharma Reports Update from Clinical Study Evaluating Oral CDK9 Inhibitor Voruciclib in Combination with Venetoclax in Patients with Relapsed and Refractory Acute Myeloid Leukemia$

Mar 26, 2024, 8:00 AM EDT - 1 year ago

MEI Pharma Reports Update from Clinical Study Evaluating Oral CDK9 Inhibitor Voruciclib in Combination with Venetoclax in Patients with Relapsed and Refractory Acute Myeloid Leukemia

Feb 13, 2024, 5:05 PM EST - 1 year ago

MEI Pharma Reports Second Quarter Fiscal Year 2024 Results and Operational Highlights

Jan 16, 2024, 5:00 PM EST - 1 year ago

MEI Pharma to Present Design of Ongoing Clinical Study Evaluating ME-344 at ASCO GI Cancers Symposium 2024

Dec 11, 2023, 12:00 PM EST - 2 years ago

MEI Pharma Reports Clinical Data on Oral CDK9 Inhibitor Voruciclib at ASH2023

Nov 9, 2023, 4:05 PM EST - 2 years ago

MEI Pharma Reports First Quarter Fiscal Year 2024 Results and Operational Highlights

Nov 8, 2023, 8:00 AM EST - 2 years ago

MEI Pharma to Present at the Stifel 2023 Healthcare Conference

Nov 6, 2023, 4:57 PM EST - 2 years ago

MEI Pharma Declares Special Cash Dividend of $1.75 Per Share of Common Stock

Nov 2, 2023, 9:00 AM EDT - 2 years ago

MEI Pharma Announces Acceptance of Abstract for Presentation at ASH 2023

Nov 1, 2023, 9:00 AM EDT - 2 years ago

MEI Pharma Enters into Agreement with Anson Funds and Cable Car Capital

Oct 17, 2023, 5:33 PM EDT - 2 years ago

MEI Pharma Recommends Stockholders Not to Consent

Oct 2, 2023, 6:00 AM EDT - 2 years ago

MEI Pharma Adopts Limited-Duration Stockholder Rights Plan

Sep 28, 2023, 5:00 PM EDT - 2 years ago

MEI Pharma Issues Statement Regarding Anson and Cable Car's Opportunistic Actions

Sep 26, 2023, 7:47 PM EDT - 2 years ago

MEI Pharma, Inc. (MEIP) Q4 2023 Earnings Call Transcript

Sep 26, 2023, 4:02 PM EDT - 2 years ago

MEI Pharma Reports Fiscal Year 2023 Results and Operational Highlights

Sep 21, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma to Report 2023 Fiscal Year End Financial Results and Provide Corporate Overview on September 26, 2023

Sep 18, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma Confirms Receipt of Director Nominations From Anson and Cable Car

Aug 16, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma Announces First Patient Dosed in Clinical Study Evaluating ME-344 Plus Bevacizumab (AVASTIN®) in Patients with Previously Treated Metastatic Colorectal Cancer

Jul 23, 2023, 2:30 PM EDT - 2 years ago

MEI Pharma Announces Results of Special Meeting of Stockholders

Jul 19, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma Reminds Shareholders to Vote Today FOR the Infinity Transaction

Jul 18, 2023, 9:00 AM EDT - 2 years ago

MEI Pharma Responds to Anson and Cable Car

Jul 17, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma Encourages Shareholders to Vote FOR the Infinity Transaction

Jul 13, 2023, 4:05 PM EDT - 2 years ago

MEI Pharma Postpones Special Meeting of Shareholders

Jul 11, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma Provides Final Reminder to Shareholders to Vote Today FOR the Merger With Infinity Pharmaceuticals

Jul 7, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma Reminds Shareholders to Vote FOR the Merger with Infinity Pharmaceuticals

Jul 5, 2023, 8:30 AM EDT - 2 years ago

ISS Recommends Infinity Pharmaceuticals Stockholders Vote FOR the Merger with MEI Pharma, Inc.

Jul 5, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma Highlights Recommendation by Leading Independent Proxy Advisory Firm ISS to Vote “FOR” Pending Transaction with Infinity Pharmaceuticals

Jun 29, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma Mails Letter to Shareholders Reiterating Value Creating Potential of Proposed Transaction with Infinity Pharmaceuticals

Jun 15, 2023, 12:08 PM EDT - 2 years ago

MEI Pharma and Infinity Pharmaceuticals Host Video Webcast Providing Overview and Update on Pending Merger to Advance Three Promising Clinical Oncology Candidates

Jun 14, 2023, 7:01 PM EDT - 2 years ago

INFINITY PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Infinity Pharmaceuticals, Inc. - INFI

Jun 13, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma Announces Planned Departure of Chief Financial Officer Brian Drazba and Appointment of Justin File as Successor

Jun 2, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma Announces Planned Departure of CEO Daniel P. Gold, Ph.D.

Jun 1, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma Board of Directors Rejects Unsolicited Proposal

May 30, 2023, 5:40 PM EDT - 2 years ago

MEI Pharma Confirms Receipt of Unsolicited Acquisition Proposal

kpfwutShr43 Nov. 15 at 1:26 PM

1 · Reply

TheBullishStockTrader Nov. 15 at 12:53 PM

$CYPH $ZEC.X $LTC.X $LITS 4 plays that about to make moves

0 · Reply

TheBullishStockTrader Nov. 15 at 3:00 AM

$LTC.X ohhhh yeaaaaa $LITS

0 · Reply

TheBullishStockTrader Nov. 14 at 7:53 PM

$LITS It's so quiet in here before it gets crazy...........

0 · Reply

TheBullishStockTrader Nov. 14 at 6:14 PM

$LITS Coin*

0 · Reply

TheBullishStockTrader Nov. 14 at 4:48 PM

$LITS i am the only LiTS guy around it seems I will be rich myself 😂

1 · Reply

TheBullishStockTrader Nov. 14 at 3:43 PM

$LITS LiTS looking like it could gap up here watching litecoin closely

0 · Reply

TheBullishStockTrader Nov. 14 at 3:30 PM

$CYPH Also it some $LITS the goal in trading is to be there before the pump thank me later 💪

0 · Reply

TheBullishStockTrader Nov. 14 at 3:17 PM

$CYPH also Front load $LITS guys bith of these are treasuries ones ZeC one LTC and both coins will be massively adopted soon

0 · Reply

soccerplayer06 Nov. 14 at 3:01 PM

$LITS curious when they will make any more moves on progressing Litecoin and its adoption. $LTC.X

0 · Reply

soccerplayer06 Nov. 13 at 12:55 PM

$LTC.X foundation and base here at $100 is incredible. 150 is next. $LITS

0 · Reply

soccerplayer06 Nov. 13 at 11:58 AM

$LTC.X added more. This is incredibly undervalued. $LITS

1 · Reply

TheBullishStockTrader Nov. 12 at 8:42 PM

$CYPH $LITS what other companies are becoming alt coin treasuries please? Are there any?

2 · Reply

00DTE Nov. 12 at 4:55 PM

$LITS who ever is running this company are either bunch amateurs or scammers. Keep you price above NAV and show some conviction.

0 · Reply

TheBullishStockTrader Nov. 11 at 4:38 PM

$LTC.X $LITS 6/18/26 $2.50 calls are a no brainer if you believe in litecoin

1 · Reply

TheBullishStockTrader Nov. 10 at 8:44 PM

$LITS If the ASST bulltards put their $ into lits which is severely undervalued holding close to 1m litecoins they could make the big $ they are hoping for with $ASST

0 · Reply

terrapin22 Nov. 10 at 8:41 PM

$LITS payback time

0 · Reply

dogbone80 Nov. 10 at 8:27 PM

$LITS Get Bullish!! Get Lits!

0 · Reply

00DTE Nov. 10 at 2:06 PM

$SPY $QQQ $LTC.X $LITS $BTC.X You wanna be bearish to the Incoming $2000 Stimulus and no PDT rule?!? Fade the market at your own risk. This could go on for a year.

0 · Reply

soccerplayer06 Nov. 10 at 12:59 PM

$LITS are earnings today? Yahoo finance mentions it is.

0 · Reply

soccerplayer06 Nov. 9 at 11:36 PM

$LITS back in positive gain territory for Lite Strategy’s million coins they have in their treasury. 😎 $LTC.X

0 · Reply

radioindiana Nov. 9 at 9:32 PM

$LITS what is the price today

0 · Reply

Market Cap	72.02M
Revenue (ttm)	0.00
Net Income (ttm)	-15.95M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	504,300
Avg Vol	1,150,942
Day's Range	N/A - N/A
Shares Out	35.66M
Stochastic %K	52%
Beta	0.30
Analysts	Hold
Price Target	N/A